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1. Introduction
  One of the most important and fatal helminthic diseases, 
caused by the larvae of the parasite not the adult itself, is 
cystic echinococcosis or hydatid disease. It is a larval stage 
of Echinococcus granulosus (E. granulosus), with canids 
as definite host and human, ruminants, and carnivorous 
as intermediate host[1]. The disease is common in most 
regions of the world especially in rural areas where usually 
ruminants are non-healthy slaughtered[2]. 
  Hydatidosis encompasses a very long period of incubation 
and during this time normally has no obvious clinical 
manifestations. Thus, diagnosis of the disease needs extra 
devices than signs and symptoms solely. For more than 
50 years, the various serologic tests have been applied for 
detection of antibodies against the disease including IgG, 
IgM, IgA and IgE[3]. Metacestod of E. granulosus is usually 
unaffected by immune response during the developing 
stage[4]. Specific antibodies against the E. granulosus
antigens remain several years after treatment of the 
disease[5], therefore many of serological tests remain 
positive even after surgery or successful chemotherapy[4,6]. 
Metacestod of E. granulosus secret a polymeric lipoprotein 
known as Antigen B[7] and is encoded by a gene family[8]. 
Antigen B is composed of 8/12, 16, 24 kDa subunits[9]. 
Some researchers have already reported trials to evaluate 
different recombinant subunits of AgB in diagnosis of 
human hydatidosis with more or less successful results[9-12] 
but regardless all these challenges still there are dark spots 
on clarification of the proper understanding of immunity 
and diagnosis of the disease.
  In the present study, 2 subunits of 12 and 16 kDa 
recombinant subunits of antigen B from E. granulosus were 
produced, purified, and then injected to rabbits. Afterwards, 
production of polyclonal antibody and inducing the humoral 
immune response were assayed by ELISA and gel diffusion.
2. Materials and methods
2.1. Production of recombinant antigens
  We previously cloned 12 and 16 kDa subunits of antigen 
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Jahangir Abdi et al./Asian Pacific Journal of Tropical Medicine (2012)355-357356
B from E. granulosus and expressed them in expression 
vector[10]. 
2.2. Induction of polyclonal antibody in rabbits
  The method was conducted essentially based on a previous 
study[13] with some modifications. Four young white male 
rabbits, 2 year-old, each 2-2.5 kg, were enrolled in the 
study. Recombinant antigens were passed through 0.22 
microns filter and emulsified with an equal volume (v/v) 
of Freund’s complete adjuvant to enhance the response to 
the immunogen. Adult rabbits were injected intradermally, 
in different limbs. Before the injection of antigens, four 
challenged rabbits were bled. Injection procedure was 
performed as follows:
  First injection: One mL antigen mixed with Freund’s 
complete adjuvant was injected with a concentration of
500 毺g antigen per mL; second injection: Two weeks later, 
one mg antigen mixed with incomplete adjuvant; third 
injection: Ten days after the second injection, one mg of 
antigen directly; and fourth injection: 10 d after the third 
injection, 500 毺g of sterile antigen. Ten days after the last 
injection all rabbits were bled and sera were tested using 
ELISA and gel diffusion.
  The study was approved by the Ethical Committee of 
Tehran University of Medical Sciences, Tehran, Iran.
2.3. Gel diffusion
  Gel diffusion was conducted as stated earlier[14]. 
2.4. ELISA
  ELISA was conducted as reported earlier[15] with some 
modifications. Briefly, the diluted r12 kDa and r16 kDa (2 毺g/mL
each) in the coating buffer were dispensed into the flat-
bottomed wells of 96-well MaxiSorpTM plates (Nunc, 
Roskilde, Denmark) and left overnight at 4 曟. After three 
washes, each well was filled with 1:200 dilution of each 
serum before the plates were incubated for 1 h at 37 曟. After 
another three washes, the conjugate of goat antirabbit-IgG 
(c-chain) with horseradish peroxidase (Sigma Chemical Co., 
Poole, Dorset, United Kingdom) was added at a dilution of 
1:10 000. After incubation, 0.4 mg/mL o-phenylenediamine 
solution (Sigma Chemical Co., Poole, Dorset, United 
Kingdom) was added. The absorbance of the contents of each 
well was then read at 492 nm, on an ELISA reader (Tecan,
M覿nnedorf, Switzerland), with a 620 nm reference filter.
3. Results
 
  Figure 1 (A) shows the result of gel diffusion analysis 
of antibody prepared from a rabbit injected with 12 kDa 
recombinant subunit and (B) shows the result of same trial 
with 16 kDa recombinant subunit. Figures 2 and 3 show 
the result of ELISA test from rabbits immunized with r12 
kDa and r16 kDa antigens, respectively. Optical density 







Figure 1. Gel diffusion results of rabbits’ sera immunized with 
recombinant r12 kDa(A) and r16 kDa(B) antigens of E. granulosus.
1: Antigen; 2: Animal serum before injection; 3: Immunized rabbit’s 
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Figure 2. Antibody titer of two rabbits immunized with r12 kDa 
subunit of antigen B from E. granulosus. 
Optical density absorbances of two rabbits before and after 












Figure 3. Antibody titer of two rabbits immunized with r16 kDa 
subunit of antigen B from E. granulosus. 
Optical density absorbances of two rabbits before and after 
immunization were 0.09 and 0.16, as well as 1.56 and 1.47, 
respectively. 
4. Discussion
  In this study, we succeeded to induce and evaluate 
polyclonal antibodies in rabbits against 12 and 16 kDa 
recombinant subunits of antigen B from E. granulosus.
  Polyclonal antibodies are important proteins utilized 
in a variety of laboratory techniques (e.g. vaccines, 
immunoblotting, immunoprecipatation, and diagnostic 
tests) in many fields of biomedical research. In the area 
of serodiagnosis and antibody production on human 
hydatidosis, antigen B and its subunits have been used 
by many researchers so far[9,11,16]. However, there are few 
studies to challenge recombinant AbB subunits on animals 
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to survey the production of polyclonal antibodies.
  Our study showed that the expression and purification 
of recombinant antigens for the production of polyclonal 
antibodies in rabbit was practical. Hashemitabar et al., 
produced polyclonal antibody against hydatid fluid, 
protoscolex, and adult E. granulosus antigens in mice 
and concluded that the level of antibody against the adult 
worms was higher than those of hydatid cyst fluid and 
protoscolex[17]. Lithowlers et al used monoclonal antibody 
for determination of antigenic component of hydatid 
cyst especially antigens 5 and B[9]. Khaled et al applied 
generation of monoclonal antibody against B8/2 antigen of 
E. granulosus and appraised its specialty with crude hydatid 
cyst antigen and other parasites’ antigens. They showed 
that this antigen had cross-reaction with Schistosoma 
mansoni antigen[18]. It has been shown that rEgP29 elicits 
high titer of specific antibody in mice after immunization[19]. 
Immunogenicity of two antigens from E. granulosus 
including EgA31 and EgTrp in mice was surveyed by ELISA 
and these antigens induced high antibody titer[20]. However, 
all these trials have been conducted to ease the process of 
obtaining polyclonal or monoclonal antibodies to utilize 
them in diagnostic or vaccination techniques. We showed 
that r12 and r16 kDa antigens of E. granulosus are capable 
to induce immune system of a laboratory animal within 4 
weeks post infection.
  In conclusion, although, the level of antibody in rabbit 
immunized with r16 kDa was higher than that of r12 kDa 
but both antigens separately or in combination might be 
candidate for vaccination or diagnosing trials. 
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